The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
Open accessAbstract
The translocation t(11;22) is a common chromosomal abnormality detected both in Ewing's sarcoma and in primitive neuroectodermal tumor cells. The translocation results in an EWS-Fli1 fusion gene, made up of the 5' half of the EWS gene on chromosome 22 fused to the 3' half of the Fli1 gene on chromosome 11. Recent studies have evaluated possible roles of the fusion gene products. However, the biological significance of EWS-Fli1 is still unknown. Using a competitive polymerase chain reaction technique, we show here that there might be a correlation between the expression levels of the EWS-Fli1 fusion gene and the proliferative activities of Ewing's sarcoma and primitive neuroectodermal tumor cells. When the EWS-Fli1 expression is inhibited by antisense oligodeoxynucleotides against the fusion RNA, the growth of the tumor cells is significantly reduced both in vitro and in vivo. The data further indicate the growth inhibition of the cells by the antisense sequence might be mediated by G0/G1 block in the cell cycle progression. These results suggest that EWS-Fli1 may play an important role in the proliferation of the tumor cells, and the EWS-Fli1 fusion RNA could be used as a target to inhibit the growth of Ewing's sarcoma and primitive neuroectodermal tumor with the specific antisense oligonucleotide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Delattre, O., Zucman, J., Plougastel, B., Desmaze, C., Melot, T., Peter, M., Kovar, H., Joubert, I., de Jong, P., Rouleau, G., et al. (1992) · Nature · doi:10.1038/359162a0 · Cited by 1,907
Quantitation of mRNA by the polymerase chain reaction.
Wang, A. M., Doyle, M. V., & Mark, D. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9717 · Cited by 1,625
Chromosomal translocations in human cancer
Rabbitts, T. H. (1994) · Nature · doi:10.1038/372143a0 · Cited by 1,503
Gilliland, G., Perrin, S., Blanchard, K., & Bunn, H. F. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2725 · Cited by 1,454
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
Wilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., & Goldberg, G. I. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71480-4 · Cited by 1,109
Delattre, O., Zucman, J., Melot, T., Garau, X. S., Zucker, J.-M., Lenoir, G. M., Ambros, P. F., Sheer, D., Turc-Carel, C., Triche, T. J., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408043310503 · Cited by 1,107
PRIMARY RESPONSE GENES INDUCED BY GROWTH FACTORS AND TUMOR PROMOTERS
Herschman, H. R. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.001433 · Cited by 1,079
Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
Crozat, A., Åman, P., Mandahl, N., & Ron, D. (1993) · Nature · doi:10.1038/363640a0 · Cited by 894
Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma
Galili, N., Davis, R. J., Fredericks, W. J., Mukhopadhyay, S., Rauscher, F. J., Emanuel, B. S., Rovera, G., & Barr, F. G. (1993) · Nature Genetics · doi:10.1038/ng1193-230 · Cited by 892
Clark, J., Rocques, P. J., Crew, A. J., Gill, S., Shipley, J., Chan, A. M.-L., Gusterson, B. A., & Cooper, C. S. (1994) · Nature Genetics · doi:10.1038/ng0894-502 · Cited by 774
Sorensen, P. H. B., Lessnick, S. L., Lopez-Terrada, D., Liu, X. F., Triche, T. J., & Denny, C. T. (1994) · Nature Genetics · doi:10.1038/ng0294-146 · Cited by 747
Ewing, J. (1972) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.22.2.95 · Cited by 583
May, W. A., Gishizky, M. L., Lessnick, S. L., Lunsford, L. B., Lewis, B. C., Delattre, O., Zucman, J., Thomas, G., & Denny, C. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5752 · Cited by 574
Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma
Barr, F. G., Galili, N., Holick, J., Biegel, J. A., Rovera, G., & Emanuel, B. S. (1993) · Nature Genetics · doi:10.1038/ng0293-113 · Cited by 555
Rabbitts, T. H., Forster, A., Larson, R., & Nathan, P. (1993) · Nature Genetics · doi:10.1038/ng0693-175 · Cited by 554
Siebert, P. D., & Larrick, J. W. (1992) · Nature · doi:10.1038/359557a0 · Cited by 530
EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts
Zucman, J., Delattre, O., Desmaze, C., Epstein, A. L., Stenman, G., Speleman, F., Fletchers, C. D. M., Aurias, A., & Thomas, G. (1993) · Nature Genetics · doi:10.1038/ng0893-341 · Cited by 502
Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor.
Ladanyi, M., & Gerald, W. L. (1994) · PubMed · Cited by 498
May, W. A., Lessnick, S. L., Braun, B. S., Klemsz, M., Lewis, B. C., Lunsford, L. B., Hromas, R., & Denny, C. T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.12.7393 · Cited by 497
A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.
Jeon, I. S., Davis, J. N., Braun, B. S., Sublett, J. E., Roussel, M. F., Denny, C. T., & Shapiro, D. N. (1995) · PubMed · Cited by 471
Myc and Max proteins possess distinct transcriptional activities
Kretzner, L., Blackwood, E. M., & Eisenman, R. N. (1992) · Nature · doi:10.1038/359426a0 · Cited by 453
Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.
Walder, R. Y., & Walder, J. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5011 · Cited by 450
Chromosome Translocation in Peripheral Neuroepithelioma
Whang-Peng, J., Triche, T. J., Knutsen, T., Miser, J., Douglass, E. C., & Israel, M. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198408303110907 · Cited by 399
Nuclear Proto-Oncogenes Fos and Jun
Ransone, L. J., & Verma, I. M. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.002543 · Cited by 391
Chromosomal Translocations in Ewing's Sarcoma
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308253090817 · Cited by 330
Cytogenetic characterization of selected small round cell tumors of childhood
Whang-Peng, J., Triche, T. J., Knutsen, T., Miser, J., Kao-Shan, S., Tsai, S., & Israel, M. A. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90001-4 · Cited by 306
Bailly, R.-A., Bosselut, R., Zucman, J., Cormier, F., Delattre, O., Roussel, M., Thomas, G., & Ghysdael, J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.5.3230-3241.1994 · Cited by 297
EWING, J. (1984) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198405000-00001 · Cited by 277
Experimental evidence for a neural origin of Ewing's sarcoma of bone.
Cavazzana, A. O., Miser, J., Jefferson, J., & Triche, T. J. (1987) · PubMed Central · Cited by 263
Sreekantaiah, C., Ladanyi, M., Rodríguez, E., & Chaganti, R. S. K. (1994) · PubMed · Cited by 215
Burdach, S., Jürgens, H., Peters, C., Nürnberger, W., Mauz-Körholz, C., Körholz, D., Paulussen, M., Pape, H., Dilloo, D., & Koscielniak, E. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.8.1482 · Cited by 214
EWS/Fli-1 chimeric protein is a transcriptional activator.
Ohno, T., Rao, V. N., & Reddy, E. S. (1993) · PubMed · Cited by 167
Giovannini, M., Biegel, J. A., Serra, M., Wang, J. Y., Wei, Y. H., Nycum, L., Emanuel, B. S., & Evans, G. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117360 · Cited by 162
Braun, B. S., Frieden, R., Lessnick, S. L., May, W. A., & Denny, C. T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4623 · Cited by 162
EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar, H., Aryee, D. N. T., Jug, G., Henöckl, C., SCHEMPER, M., Delattre, O., Thomas, G. D., & Gadner, H. (1996) · PubMed · Cited by 147
Langer, S. J., Bortner, D. M., Roussel, M. F., Sherr, C. J., & Ostrowski, M. C. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5355-5362.1992 · Cited by 146
Haeuptle, M. T., Frank, R. W., & Dobberstein, B. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.3.1427 · Cited by 141
Loss of tumorigenicity of Ewing's sarcoma cells expressing antisense RNA to EWS-fusion transcripts.
Ouchida, M., Ohno, T., Fujimura, Y., Rao, V. N., & Reddy, E. S. P. (1995) · PubMed · Cited by 136
Ladenstein, R. L., Lasset, C., Pinkerton, R., Jm, Z., Peters, C., Burdach, S. E. G., Pardo, N., Dallorso, S., Coze, C., & Dollorso, G. (1995) · PubMed · Cited by 133
The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities.
Mao, X., Miesfeldt, S., Yang, H., Leiden, J. M., & Thompson, C. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32437-7 · Cited by 132
Roussel, M. F., Jn, D., Jl, C., Ghysdael, J., & Hiebert, S. W. (1994) · PubMed · Cited by 121
Progress toward oligonucleotide therapeutics: pharmacodynamic properties
Crooke, S. T. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.6.7682523 · Cited by 119
Thiele, C. J., McKeon, C., Triche, T. J., Ross, R. A., Reynolds, C. P., & Israel, M. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113137 · Cited by 109
Genes induced by serum growth factors
Lau, L. F., & Nathans, D. (1991) · Molecular aspects of cellular regulation · doi:10.1016/b978-0-444-81382-4.50019-0 · Cited by 96
Chen, K. G., Jaffrézou, J., Fleming, W., Durán, G. E., & Sikic, B. I. (1994) · PubMed · Cited by 94
Antisense RNA inhibits splicing of pre‐mRNA in vitro.
Munroe, S. H. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03100.x · Cited by 90
Ewing sarcoma of the pelvis. Clinicopathological features and treatment.
Frassica, F. J., Frassica, D. A., Pritchard, D. J., Schomberg, P. J., Wold, L. E., & Sim, F. H. (1993) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199310000-00006 · Cited by 83
Proliferative activation of quiescent Rat-1A cells by delta FosB.
Nakabeppu, Y., Oda, S., & Sekiguchi, M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4157 · Cited by 82
Zhang, L., Lemarchandel, V., Roméo, P., Ben‐David, Y., Greer, P. K., & Bernstein, A. (1993) · PubMed · Cited by 77
Peten, E. P., Striker, L. J., Carome, M. A., Elliott, S. J., Yang, C., & Striker, G. E. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.6.1571 · Cited by 70
Tanaka, K., Iwamoto, Y., Ito, Y., Ishibashi, T., Nakabeppu, Y., Sekiguchi, M., & Sugioka, Y. (1995) · PubMed · Cited by 67
Self-citationProliferative Activation of Quiescent Rat-1A Cells by ΔFosB
Nakabeppu, Y., Oda, S., & Sekiguchi, M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4157-4166.1993 · Cited by 23
Cited by
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.006 · Cited by 956
Nanotechnology: Intelligent Design to Treat Complex Disease
Couvreur, P., & Vauthier, C. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0284-8 · Cited by 948
Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 567
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications
Vauthier, C., Dubernet, C., Fattal, E., Pinto-Alphandary, H., & Couvreur, P. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(03)00041-3 · Cited by 527
Metadata
- Authors
- Tanaka, K., Iwakuma, T., Harimaya, K., Sato, H., & Iwamoto, Y.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-01-15
- Volume
- 99
- Issue
- 2
- Pages
- 239-247
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2036463815
- Cited by
- 277
- References
- 53
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.